RGC
Regencell Bioscience Holdings Ltd
NASDAQ: RGC · HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERIC
$28.95
-0.34% today
Updated 2026-04-29
Market cap
$14.32B
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-0.01
Dividend yield
—
52W range
$2 – $84
Volume
0.1M
Regencell Bioscience Holdings Ltd (RGC) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $2.53B | $2.47B | $2.63B | $2.60B | $2.64B | $2.49B | $2.34B | $2.21B | $2.70B | $2.54B | $2.63B | $2.65B | $2.84B | $243307.00 | $514018.00 | $340134.00 | $18.02M | $12.62M | $8.44M | $5.76M |
| Cash & equivalents | $196.00M | $162.00M | $435.00M | $170.00M | $328.10M | $205.30M | $253.00M | $109.50M | $280.90M | $147.10M | $219.60M | $246.50M | $228.80M | $243307.00 | $386979.00 | $59413.00 | $6.42M | $1.56M | $2.96M | $2.42M |
| Current assets | $262.00M | $241.00M | $525.00M | $273.00M | $428.90M | $346.50M | $403.50M | $257.80M | $465.10M | $341.40M | $438.20M | $446.90M | $463.30M | $243307.00 | $386979.00 | $66849.00 | $16.44M | $11.62M | $8.11M | $4.90M |
| Total liabilities | $2.50B | $2.49B | $2.75B | $2.84B | $2.88B | $2.98B | $2.91B | $2.91B | $3.42B | $3.43B | $3.51B | $3.48B | $3.70B | $2.08M | $3.16M | $4.34M | $938032.00 | $632320.00 | $219512.00 | $895308.00 |
| Current liabilities | $693.00M | $556.00M | $527.00M | $366.00M | $396.50M | $469.00M | $400.70M | $387.50M | $506.40M | $477.00M | $551.30M | $510.00M | $561.40M | $2.08M | $3.16M | $4.34M | $577764.00 | $606914.00 | $193578.00 | $663673.00 |
| Long-term debt | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Shareholder equity | $29.00M | $-22.00M | $-119.00M | $-241.00M | $-246.10M | $-490.30M | $-570.90M | $-696.80M | $-713.40M | $-894.80M | $-877.80M | $-839.10M | $-855.90M | $-1.84M | $-2.65M | $-4.00M | $17.07M | $12.03M | $8.22M | $4.86M |
| Retained earnings | $44.00M | $30.00M | $42.00M | $24.00M | $47.00M | $9.40M | $15.70M | $1.40M | $71.80M | $48.40M | $64.20M | $96.50M | $70.90M | $-1.84M | $-2.65M | $-4.00M | $-11.44M | $-17.32M | $-21.62M | $-25.20M |
| Accounts receivable | — | — | — | — | $69.00M | — | $99.80M | $104.30M | $129.40M | — | $153.10M | $155.10M | $184.00M | — | — | $7436.00 | $27598.00 | $56548.00 | $152778.00 | — |
| Inventory | $7.00M | $8.00M | $8.00M | $8.00M | $12.30M | $14.70M | $14.80M | $17.80M | $19.00M | $17.80M | $22.40M | $20.90M | $22.90M | — | — | $-7436.00 | $-27598.00 | $-56548.00 | $-152778.00 | — |
| Goodwill | $223.00M | $214.00M | $181.00M | $178.00M | $178.80M | $178.80M | $178.80M | $267.80M | $320.40M | $320.40M | $328.70M | $327.00M | $345.80M | — | — | — | — | — | — | — |